11:18 AM EDT, 04/23/2024 (MT Newswires) -- Bausch Health ( BHC ) will report Q1/24 results on May 2, one day after Bausch + Lomb's ( BLCO ) Q1 results.

RBC estimates Q1/24 revenue of $2.13 billion (FactSet cons. $2.15 billion) and adj. EBITDA of $682 million (FactSet cons. $730 million). Analyst Douglas Miehm expects the focus to be on a potential BLCO distribution to BHC shareholders and the factors influencing such a decision. (in US$).

"We believe that following the Appellate Court's ruling, BHC stands in a stronger position to move forward with a potential BLCO distribution. However, Amneal's ANDA submission has likely added additional complexity to the situation," he said.

Target lowered by US$1, to US$11, maintain Sector Perform.

Price: 11.66, Change: +0.08, Percent Change: +0.69